MedTrace Logo

Hepatitis B Antigen Kidney Graft Into Protective Level Hepatitis B Antibody Recipients

NCT02044588 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2014-01-24

No results posted yet for this study

Summary

To determine the safety of using kidney organ from hepatitis B surface antigen positive donor, the author conducted the single-center, prospective study of the use of these kidneys for recipients who have protective level of hepatitis B surface antibodies.

Conditions

  • HBsAg(+) Donor Kidney Allograft
  • HBsAg(-) Donor Kidney Allograft

Interventions

BIOLOGICAL

HBsAg positive kidney allograft donor

Sponsors & Collaborators

  • Chulalongkorn University

    lead OTHER

Principal Investigators

  • Wiwat Chancharoenthana, MD, MSc · Chulalongkorn University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-01-31
Primary Completion
2014-12-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02044588 on ClinicalTrials.gov